Tesla’s Sky-High Valuation is Unjustified, Says Analyst, , on October 15, 2020 at 12:31 am

By
On October 15, 2020
Tags:

When it comes to Tesla (TSLA), valuation is an unfashionable metric. For the electric car maker, there has been a major disconnect between the fundamentals and the valuation, and now, one analyst is getting to the bottom of it.Needham’s Rajvindra Gill tells clients he has never seen a stock “rise that much that fast with such little regard to past fundamentals.” Shares have skyrocketed 451% year-to-date, compared to the S&P 500’s 8% gain. To this end, he took a look at TSLA’s unprecedented valuation to eliminate the noise surrounding this company.As part of this analysis, Gill asked “three fundamental questions: 1) Have Street estimates actually moved in sympathy with the meteoritic rise in the share price during two critical breakpoints (July 2019 to March 2020 and March 2020 till today)? 2) assuming the long view, what stock price does a 10-year discounted flow analysis (DCF) yield? and 3) in the relative near-term, what are the ranges of share prices when applying leading technology and AI P/E multiples to a range of EPS scenarios?”Looking at these breakpoints, between July 2019 to March 2020, shares appreciated by as much as 386%. At the same time, forward sales and EPS estimates moved sideways or in some cases, actually declined. “This started to create a large disconnect between TSLA stock and its underlying fundamentals,” Gill noted.From March 2020 to the present, even though some estimates such as CY22 non-GAAP EPS grew by 42%, the stock rose by as much as 490%, creating “a further disconnect between the price and the stock’s underlying fundamentals,” in Gill’s opinion.Performing a 10-year DCF-based intrinsic value analysis, Gill estimated a total 10-year sales CAGR of 21% to 2029, which would imply that TSLA will become the top car manufacturer by units sold. The conclusion? Gill’s 2029 base case indicates a share price of $365, or 14% downside at current levels when discounting 10-years of free cash flow back to today’s levels.As for the multiples-based stock value on CY 2022 estimates, it further demonstrates that shares are overvalued, according to Gill.Expounding on this, the analyst stated, “Tesla bulls argue that the company deserves a multiple that is in the range of leading technology and Artificial Intelligence companies, such as Amazon, Apple, Facebook, Google, Netflix and NVIDIA, which are growing quickly and profitable, and trade at approximately 35-45x forward EPS. While Tesla has demonstrated sales growth, it has not shown the consistent profitability that warrants such a multiple, in our view.”Even if a “generous leading-technology-firm multiple of 45x-50″ is applied to a bull case EPS estimate of $6.60, the stock price target clocks in at $330, reflecting 24% downside from current levels.Therefore, Gill continues to give TSLA an Underperform (i.e. Sell) rating, without suggesting a specific price target. (To watch Gill’s track record, click here)Turning now to the rest of the Street, other analysts are cautious about TSLA. With 7 Buys, 13 Holds and 10 Sells, the word on the Street is that TSLA is a Hold. At $326.88, the average price target implies 27% downside potential. (See TSLA stock analysis on TipRanks)Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.,

Tesla’s Sky-High Valuation is Unjustified, Says AnalystWhen it comes to Tesla (TSLA), valuation is an unfashionable metric. For the electric car maker, there has been a major disconnect between the fundamentals and the valuation, and now, one analyst is getting to the bottom of it.Needham’s Rajvindra Gill tells clients he has never seen a stock “rise that much that fast with such little regard to past fundamentals.” Shares have skyrocketed 451% year-to-date, compared to the S&P 500’s 8% gain. To this end, he took a look at TSLA’s unprecedented valuation to eliminate the noise surrounding this company.As part of this analysis, Gill asked “three fundamental questions: 1) Have Street estimates actually moved in sympathy with the meteoritic rise in the share price during two critical breakpoints (July 2019 to March 2020 and March 2020 till today)? 2) assuming the long view, what stock price does a 10-year discounted flow analysis (DCF) yield? and 3) in the relative near-term, what are the ranges of share prices when applying leading technology and AI P/E multiples to a range of EPS scenarios?”Looking at these breakpoints, between July 2019 to March 2020, shares appreciated by as much as 386%. At the same time, forward sales and EPS estimates moved sideways or in some cases, actually declined. “This started to create a large disconnect between TSLA stock and its underlying fundamentals,” Gill noted.From March 2020 to the present, even though some estimates such as CY22 non-GAAP EPS grew by 42%, the stock rose by as much as 490%, creating “a further disconnect between the price and the stock’s underlying fundamentals,” in Gill’s opinion.Performing a 10-year DCF-based intrinsic value analysis, Gill estimated a total 10-year sales CAGR of 21% to 2029, which would imply that TSLA will become the top car manufacturer by units sold. The conclusion? Gill’s 2029 base case indicates a share price of $365, or 14% downside at current levels when discounting 10-years of free cash flow back to today’s levels.As for the multiples-based stock value on CY 2022 estimates, it further demonstrates that shares are overvalued, according to Gill.Expounding on this, the analyst stated, “Tesla bulls argue that the company deserves a multiple that is in the range of leading technology and Artificial Intelligence companies, such as Amazon, Apple, Facebook, Google, Netflix and NVIDIA, which are growing quickly and profitable, and trade at approximately 35-45x forward EPS. While Tesla has demonstrated sales growth, it has not shown the consistent profitability that warrants such a multiple, in our view.”Even if a “generous leading-technology-firm multiple of 45x-50″ is applied to a bull case EPS estimate of $6.60, the stock price target clocks in at $330, reflecting 24% downside from current levels.Therefore, Gill continues to give TSLA an Underperform (i.e. Sell) rating, without suggesting a specific price target. (To watch Gill’s track record, click here)Turning now to the rest of the Street, other analysts are cautious about TSLA. With 7 Buys, 13 Holds and 10 Sells, the word on the Street is that TSLA is a Hold. At $326.88, the average price target implies 27% downside potential. (See TSLA stock analysis on TipRanks)Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

,

Instant Quote

Enter the Stock Symbol.

Select the Exchange.

Select the Type of Security.

Please enter your First Name.

Please enter your Last Name.

Please enter your phone number.

Please enter your Email Address.

Please enter or select the Total Number of Shares you own.

Please enter or select the Desired Loan Amount you are seeking.

Please select the Loan Purpose.

Please select if you are an Officer/Director.

High West Capital Partners, LLC may only offer certain information to persons who are “Accredited Investors” and/or “Qualified Clients” as those terms are defined under applicable Federal Securities Laws. In order to be an “Accredited Investor” and/or a “Qualified Client”, you must meet the criteria identified in ONE OR MORE of the following categories/paragraphs numbered 1-20 below.

High West Capital Partners, LLC cannot provide you with any information regarding its Loan Programs or Investment Products unless you meet one or more of the following criteria. Furthermore, Foreign nationals who may be exempt from qualifying as a U.S. Accredited Investor are still required to meet the established criteria, in accordance with High West Capital Partners, LLC’s internal lending policies. High West Capital Partners, LLC will not provide information or lend to any individual and/or entity that does not meet one or more of the following criteria:

1) Individual with Net Worth in excess of $1.0 million. A natural person (not an entity) whose net worth, or joint net worth with his or her spouse, at the time of purchase exceeds $1,000,000 USD. (In calculating net worth, you may include your equity in personal property and real estate, including your principal residence, cash, short-term investments, stock and securities. Your inclusion of equity in personal property and real estate should be based on the fair market value of such property less debt secured by such property.)

2) Individual with $200,000 individual Annual Income. A natural person (not an entity) who had individual income of more than $200,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

3) Individual with $300,000 Joint Annual Income. A natural person (not an entity) who had joint income with his or her spouse in excess of $300,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

4) Corporations or Partnerships. A corporation, partnership, or similar entity that has in excess of $5 million of assets and was not formed for the specific purpose of acquiring an interest in the Corporation or Partnership.

5) Revocable Trust. A trust that is revocable by its grantors and each of whose grantors is an Accredited Investor as defined in one or more of the other categories/paragraphs numbered herein.

6) Irrevocable Trust. A trust (other than an ERISA plan) that (a)is not revocable by its grantors, (b) has in excess of $5 million of assets, (c) was not formed for the specific purpose of acquiring an interest, and (d) is directed by a person who has such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of an investment in the Trust.

7) IRA or Similar Benefit Plan. An IRA, Keogh or similar benefit plan that covers only a single natural person who is an Accredited Investor, as defined in one or more of the other categories/paragraphs numbered herein.

8) Participant-Directed Employee Benefit Plan Account. A participant-directed employee benefit plan investing at the direction of, and for the account of, a participant who is an Accredited Investor, as that term is defined in one or more of the other categories/paragraphs numbered herein.

9) Other ERISA Plan. An employee benefit plan within the meaning of Title I of the ERISA Act other than a participant-directed plan with total assets in excess of $5 million or for which investment decisions (including the decision to purchase an interest) are made by a bank, registered investment adviser, savings and loan association, or insurance company.

10) Government Benefit Plan. A plan established and maintained by a state, municipality, or any agency of a state or municipality, for the benefit of its employees, with total assets in excess of $5 million.

11) Non-Profit Entity. An organization described in Section 501(c)(3) of the Internal Revenue Code, as amended, with total assets in excess of $5 million (including endowment, annuity and life income funds), as shown by the organization’s most recent audited financial statements.

12) A bank, as defined in Section 3(a)(2) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

13) A savings and loan association or similar institution, as defined in Section 3(a)(5)(A) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

14) A broker-dealer registered under the Exchange Act.

15) An insurance company, as defined in Section 2(13) of the Securities Act.

16) A “business development company,” as defined in Section 2(a)(48) of the Investment Company Act.

17) A small business investment company licensed under Section 301 (c) or (d) of the Small Business Investment Act of 1958.

18) A “private business development company” as defined in Section 202(a)(22) of the Advisers Act.

19) Executive Officer or Director. A natural person who is an executive officer, director or general partner of the Partnership or the General Partner, and is an Accredited Investor as that term is defined in one or more of the categories/paragraphs numbered herein.

20) Entity Owned Entirely By Accredited Investors. A corporation, partnership, private investment company or similar entity each of whose equity owners is a natural person who is an Accredited Investor, as that term is defined in one or more of the categories/paragraphs numbered herein.

Please read the notice above and check the box below to continue.

Singapore

+65 3105 1295

Taiwan

Coming Soon!

Hong Kong

R91, 3rd Floor,
Eton Tower, 8 Hysan Ave.
Causeway Bay, Hong Kong
+852 3002 4462

Market Coverage